Vanda Pharmaceuticals VNDA
NASDAQ VNDA
$4.13 +0.05 (+1.23%)
As of: Nov 11, 2026 · 12:04 PM EST

Vanda Pharmaceuticals (VNDA) Non Operating Income (2009 - 2010)

Updated

Analysis

Vanda Pharmaceuticals (VNDA) Non Operating Income (2009 - 2010) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -130.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Vanda Pharmaceuticals 246.71 Mn -529.97 Mn 65.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2010 85,433.00
Mar 31, 2010 47,401.00
Dec 31, 2009 4,706.00
Sep 30, 2009 10.56 Mn
Jun 30, 2009 21,163.00
Mar 31, 2009 53,387.00
API Access

Vanda Pharmaceuticals Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=VNDA&period=max&api_key=YOUR_API_KEY